( October 6, 2026, 10:53 AM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court on Oct. 5 invited the solicitor general to file a brief expressing the views of the United States on a petition for a writ of certiorari by drug makers seeking consideration of two antitrust questions after the Second Circuit U.S. Court of Appeals vacated the dismissal of a putative class complaint by federally funded health centers and clinics alleging that there is a concerted effort to restrict drug discounts offered to contract pharmacies....